You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.
BIO President and CEO Jim Greenwood and BIO Board Chair Dr. Stephen Sherwin discuss the need to ensure that health care reform promotes and preserves innovation, particularly in a pathway for biosimilars and the use of comparative effectiveness data.
|
September 6, 2012
|
August 2, 2012
|
July 18, 2012
|
June 20, 2012
|
|
June 15, 2012
|
June 15, 2012
|
June 11, 2012
|
June 8, 2012
|